encyclopedia jump navigation jump search ulcerative_colitis ulcerative_colitis image colon ulcerative_colitis 
surface colon place 
symptom pain blood weight loss fever complication inflammation eye joint liver colon cancer onset year year duration term cause method tissue biopsy diagnosis disease colitis treatment change medication surgery mesalazine steroid azathioprine therapy frequency people death 
ulcerative_colitis ulcerative_colitis condition result inflammation ulcer colon rectum symptom disease pain diarrhea blood weight loss fever symptom symptom period symptom flare complication megacolon inflammation eye joint liver colon cancer 
cause ulcerative_colitis theory system dysfunction genetics change gut bacteria factor rate world result exposure infection diet lifestyle removal appendix age diagnosis colonoscopy tissue biopsy kind bowel disease disease colitis 
change diet diet symptom medication symptom remission mesalazine sulfasalazine steroid azathioprine therapy removal colon surgery disease treatment complication colon cancer removal colon rectum disease 
disease people year people individual disease north america europe region people year male female proportion ulcerative_colitis disease affect people united states treatment risk death population description ulcerative_colitis content 
sign symptom gastrointestinal feature cause factor factor disease theory diagnosis diagnosis management surgery recolonization medicine progression remission cancer cholangitis mortality feature epidemiology united states canada united kingdom research case reference link 
sign symptom sign symptom disease ulcerative_colitis blood fever disease weight loss 
presentation ulcerative_colitis extent disease process 
patient blood mucus onset period week 
weight loss blood examination 
inflammation disease bleed gi tract rate 
disease degree pain discomfort bowel movement cramp bowel movement 
ulcerative_colitis process part body 
extra-intestinal symptom sign disease knee teenager adult 
diagnosis ulcerative_colitis onset manifestation 
extent involvement diagram intestine 
ulcerative_colitis rectum colon 
disease extent involvement disease 
colitis enema involvement rectum involvement colon portion colon rectum 
colitis involvement colon patient side flexure begine colon colitis reach enema involvement colon rectum cecum intestine 
severity disease pseudopolyp patient ulcerative_colitis colectomy specimen 
addition extent involvement people severity disease 
disease correlate stool blood sign toxicity erythrocyte sedimentation rate esr protein crp 
pain cramp 
patient fact feel need bowel effort pain cramp output 
disease correlate stool sign toxicity 
patient transfusion pain fever   
disease correlate stool day bowel movement evidence toxicity fever tachycardia esr crp 
disease bowel movement toxicity tenderness distension blood transfusion requirement dilation expansion 
patient category inflammation layer motility megacolon 
membrane perforation 
disease death 
feature patient ulcerative_colitis ulcer tongue lip palate pharynx 
ulcerative_colitis autoimmune origin patient symptom complication colon 
frequency manifestation 
ulcer mouth iritis uveitis inflammation eye iris arthritis large-joint joint joint hand feet arthritis spine arthritis spine skin erythema panniculitis inflammation tissue extremity ulcerate lesion skin thrombosis embolism anemia deformity end finger cholangitis disease inflammation bile duct 
cause ulcerative_colitis factor genetics stress role 
component etiology ulcerative_colitis 
aggregation ulcerative_colitis family twin concordance rate twin concordance rate difference incidence marker linkage 
region genome ulcerative_colitis order discovery chromosome locy fault disorder gene 
example chromosome band 1p36 region bowel disease 
region transporter protein 
potential region cell scaffold protein family 
leukocyte antigen association work 
fact linkage chromosome candidate 
autoimmune disorder neurovisceral porphyria ulcerative_colitis disease disease dermatitis diabete arthritis scleroderma disease scleritis 
physician alert porphyria family autoimmune disorder care use porphyrinogenic drug 
hypothese factor pathogenesis ulcerative_colitis 
diet colon substance inflammation factor role pathogenesis ulcerative_colitis disease 
study association study association sugar prevalence ulcerative_colitis intake fat vitamin risk ulcerative_colitis factor development relapse disease meat protein beverage etiology ulcerative_colitis diet patient ulcerative_colitis animal model disease 
theory sulfur factor gut sulfide detoxification addition diet breastfeed report protection breastfeed development ibd 
study effect study isotretinoin increase rate ulcerative_colitis 
ulcerative_colitis autoimmune disease t-cell colon contrast disease area tract outside colon ulcerative_colitis rectum colon involvement ileum 
backwash ileitis patient pancolitis significance ulcerative_colitis comorbidity symptom area body system 
removal intestine disease alternative theory factor disease ulcerative_colitis risk smoker risk smoker age onset year peak incidence year 
level bacteria person ulcerative_colitis level hydrogen intestine 
theory symptom disease effect hydrogen cell intestine 
infection avium subspecy paratuberculosis cause ulcerative_colitis disease disease ulcerative_colitis response 
amount sulfate-reduce bacteria patient ulcerative_colitis concentration ga hydrogen 
mucosa barrier cell lamina propria barrier 
acid beta oxidation pathway carbon dioxide ketone body 
supply nutrient barrier 
study hydrogen role pathway chain dehydrogenase enzyme pathway 
benefit smoke ulcerative_colitis hydrogen cyanide cigarette smoke hydrogen isothiocyanate sulfide pathway study sulfur meat alcohol risk relapse patient remission 
ulcerative_colitis patient bleed desire bowel passage stool pain 
severity disease presentation therapy 
patient disease bowel movement sign toxicity 
individual ulcerative_colitis bowel movement 
patient ulcerative_colitis disease presentation 
patient disease sign toxicity fever tachycardia anemia 
patient colitis megacolon bowel movement day distention tenderness evidence edema case bowel dilation 
people colectomy colon time surgery 
diagnosis biopsy crypt abscess find ulcerative_colitis 
workup ulcerative_colitis 
blood count anemia platelet count study function test diarrhea hypomagnesemia failure 
liver function test screen bile duct involvement cholangitis 
x-ray stool culture rule parasite cause 
sedimentation rate sedimentation rate process 
protein level indication inflammation 
type endoscopy presence ulcer intestine trial enema 
ulcerative_colitis disease causation inquiry factor disease 
colitis activity index severity symptom biopsy sample infiltration bluepurple mucosa distortion crypt 
test diagnosis ulcerative_colitis endoscopy 
colonoscopy cecum entry ileum diagnosis ulcerative_colitis 
sigmoidoscopy diagnosis 
physician extent exam colitis risk perforation colon 
find ulcerative_colitis 
loss appearance colon redness mucosa friability mucosa ulceration 
ulcerative_colitis rectum rectum 
degree involvement proctitis inflammation rectum left colitis inflammation colon 
biopsies mucosa ulcerative_colitis disease 
sample time endoscopy 
pathology ulcerative_colitis distortion crypt architecture inflammation crypt crypt abscess hemorrhage cell lamina propria 
case picture analysis role diagnosis management 
contrast biopsy analysis progression disease treatment 
diagnosis image ulcerative_colitis side colon 
image ulceration loss architecture 
disease appearance fact ulcerative_colitis challenge 
condition manner ulcerative_colitis 
disease colitis stool culture parasite inflammation 
case ulcerative_colitis outcome use corticosteroid colitis colitis upset administration antibiotics colitis blood supply intestine radiation colitis patient radiotherapy chemical colitis introduction chemical colon enema procedure 
cancer flare colitis vice 
malignancy colitis treatment 
disease symptom ulcerative_colitis disease bowel disease colon symptom 
disease course treatment 
case difference case disease colitis 
find disease ulcerative_colitis ileum involvement colon involvement involvement involvement anus bile duct involvement increase rate cholangitis rate distribution disease area inflammation skip lesion area inflammation endoscopy ulcer ulcer depth inflammation tissue biopsy crypt granuloma crypt granuloma 
management article management ulcerative_colitis 
treatment ulcerative_colitis extent involvement disease severity 
goal remission medication administration maintenance medication relapse 
concept induction remission maintenance remission 
medication remission overlap treatment 
physician treatment remission relief symptom heal colon line term treatment remission complication 
ulcerative_colitis hospitalisation exclusion infection corticosteroid 
stage disease fiber diet 
ulcerative_colitis number medication drug mesalazine 
prednisone heal property risk benefit treatment 
medication azathioprine agent people remission 5-asa corticosteroid 
treatment risk factor risk cancer teenager adult tuberculosis heart_failure side effect 
formulation budesonide fda treatment ulcerative_colitis january tofacitinib treatment ulcerative_colitis  medication term use condition evidence methotrexate benefit remission people ulcerative_colitis use drug benefit drug treatment allergy promise combination therapy study absorption drug secretion result concentration site inflammation 
drug histamine secretion mast cell inflammation 
agent therapy mild ulcerative_colitis year 
acid 5-asa component drug aim compound intestine efficacy reduction side effect moiety 
drug remission ulcerative_colitis suppository foam enema formulation 5-asa colitis rectum sigmoid colon treatment 
treatment tnf inhibitor adalimumab golimumab people ulcerative_colitis corticosteroid 
vedolizumab remission response rate ulcerative_colitis medication option person corticosteroid immunomodulator azathioprine mesalazine 
biologics side effect risk extra-intestinal cancer heart_failure weaken system ability system infection reactivation infection tuberculosis 
reason patient treatment test hepatitis tuberculosis year 
disease ulcerative_colitis prevalence smoker non-smoker study nicotine patch improvement 
study united kingdom patient nicotine patch conjunction treatment resolution symptom 
placebo-control trial united states patient patch improvement placebo use nicotine patch addition standard treatment mesalazine relapse occurrence rate treatment use nicotine 
iron supplementation 
loss blood tract inflammation guideline monitor anemia blood test month disease disease disease control disease iron_deficiency iron supplement 
form treatment severity anemia guideline 
iron patient side effect compliance issue iron patient side effect guideline iron case anemia level gl 
surgery management disease ulcerative_colitis antibiotics surgery removal part removal colon 
disease aspect ulcerative_colitis removal intestine symptom 
procedure event perforation carcinoma 
surgery patient colitis megacolon 
patient symptom drug surgery quality life 
ulcerative_colitis part body tract 
case manifestation disease removal colon 
option ulcerative_colitis bowel pouch procedure 
two- procedure bowel stump anus ileostomy 
part surgery step six- twelve-month interval surgery 
step surgery pouch patient bowel pouch stump patient bowel system 
ileostomy time patient bowel function step procedure pouch stump patient time patient ileostomy bowel function 
surgery ileostomy patient bowel function 
type leukocyte granulocyte monocyte trial result trial recolonization 
number trial potential treatment ulcerative_colitis 
type escherichia coly remission patient year type probiotic effect 
citation probiotics work inflammation disease turn body cell messenger cell 
cell aid balance intestine inflammation infusion probiotics enema 
ulcerative_colitis bacteriotherapy treatment difficile infection time epithelium 
response ulcerative_colitis study report sufferer remission cause ulcerative_colitis infection pathogen 
infection imbalance flora cycle inflammation recolonize colon bacteria bowel 
case patient remission year 
bowel disease patient treatment variety treatment show promise research 
research animal study study fiber mean plant matter decade maintenance bowel function 
note brassica constituent ulcer tract fish oil acid epa fish oil leukotriene activity factor inflammation 
therapy study support dosage 
dosage epa mgday condition fish oil vitamin people ibd chain acid butyrate enema 
cell colon butyrate content intestine energy source 
amount butyrate decrease rectum 
butyrate level intestine factor disease 
butyrate enema result 
citation medication patient ulcerative_colitis 
compound effect ulcerative_colitis hypothesis moiety sulfasalazine activity addition component control trial medication rate relapse medication conjunction sulfasalazine therapy use nematode ulcerative_colitis premise hygiene hypothesis 
study corticosteroid colitis mice trial helminth infection rhesus monkey diarrhea condition ulcerative_colitis human remission symptom animal trial ova human therapy trial 
therapy conjunction medication remission people ulcerative_colitis 
effect therapy ulcerative_colitis 
complication disease ulcerative_colitis deficiency risk colon cancer risk prevalence complication female male cholangitis female male female male female male female male 
progression remission 
section source 
section citation source 
january  template message 
patient ulcerative_colitis course period disease inactivity flare disease 
patient proctitis colitis course progress disease remission absence therapy 
patient disease remission rate remission severity disease 
risk cancer patient ulcerative_colitis year involvement flexure 
patient proctitis risk patient screen colonoscopy biopsy dysplasia year disease activity year interval cholangitis 
ulcerative_colitis association cholangitis psc disorder bile duct 
patient ulcerative_colitis cholangitis mortality 
research difference risk patient ulcerative_colitis background population 
distribution background population disease quality life lifespan 
change ulcerative_colitis loss pattern mucosa loss effacement valve stricture epidemiology 
distribution ulcerative_colitis disease number case year ulcerative_colitis canada new zealand scotland kingdom age 
peak onset decade life rate location location europe united states 
disease rate ulcerative_colitis jew decrease person descent caucasian african hispanics asian age appendicitis tobacco use development ulcerative_colitis tobacco use risk disease united states 
number case ulcerative_colitis united states year number people united states canada 
canada number case year population case 
number people united kingdom 
united kingdom people condition year number people 
people united kingdom ulcerative_colitis research 
therapy whipworm suis control trial iowa benefit patient ulcerative_colitis therapy hygiene hypothesis absence helminth colon patient world inflammation 
helminthic therapy fecal characteristic cell response area ulcerative_colitis overproduction 
generation antisense messenger rna base pair interaction order expression response extravasation activation leukocyte blood cell tissue expression mucosa ulcerative_colitis sufferer production disease activity target treatment ulcerative_colitis 
gram bacteria lumen time relapse ulcerative_colitis 
series drug development inflammation process ion channel inflammation cascade kca31 study rat mice inhibition kca31 production cytokine 
colon inflammation case article list people ulcerative_colitis 
